Ecolab Given Consensus Recommendation of “Buy” by Analysts (NYSE:ECL)

Share on StockTwits

Ecolab (NYSE:ECL) has received a consensus rating of “Buy” from the ten ratings firms that are covering the stock, American Banking News reports. Three analysts have rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average twelve-month price target among brokers that have issued a report on the stock in the last year is $119.60.

Several analysts have recently commented on the stock. Analysts at Jefferies Group raised their price target on shares of Ecolab from $123.00 to $128.00 in a research note on Wednesday. They now have a “buy” rating on the stock. Separately, analysts at Oppenheimer raised their price target on shares of Ecolab from $113.00 to $129.00 in a research note on Tuesday, June 3rd. They now have an “outperform” rating on the stock. Finally, analysts at Zacks reiterated a “neutral” rating on shares of Ecolab in a research note on Tuesday, April 29th. They now have a $110.00 price target on the stock.

Shares of Ecolab (NYSE:ECL) opened at 109.59 on Friday. Ecolab has a 1-year low of $89.95 and a 1-year high of $112.27. The stock’s 50-day moving average is $109.1 and its 200-day moving average is $106.1. The company has a market cap of $32.899 billion and a P/E ratio of 33.90.

Ecolab (NYSE:ECL) last issued its quarterly earnings data on Monday, April 28th. The company reported $0.74 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.74. The company had revenue of $3.34 billion for the quarter, compared to the consensus estimate of $3.32 billion. During the same quarter in the previous year, the company posted $0.60 earnings per share. The company’s revenue for the quarter was up 16.2% on a year-over-year basis. Analysts expect that Ecolab will post $4.18 EPS for the current fiscal year.

Ecolab Inc (NYSE:ECL) develops and markets products and services for the hospitality, foodservice, healthcare and industrial markets.

Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.

Latest News

Insider Selling: AMN Healthcare Services Insider Sells 4,800 Shares of Stock
Insider Selling: AMN Healthcare Services Insider Sells 4,800 Shares of Stock
Insider Selling: Akorn Director Sells 13,800 Shares of Stock
Insider Selling: Akorn Director Sells 13,800 Shares of Stock
Seagate Technology PLC Insider Douglas J. Dehaan Sells 4,024 Shares
Seagate Technology PLC Insider Douglas J. Dehaan Sells 4,024 Shares
Jazz Pharmaceuticals plc – CMO Jeffrey K. Tobias Sells 1,000 Shares
Jazz Pharmaceuticals plc – CMO Jeffrey K. Tobias Sells 1,000 Shares
Insider Selling: Donald R. M. Quick Sells 23,750 Shares of McEwen Mining Stock
Insider Selling: Donald R. M. Quick Sells 23,750 Shares of McEwen Mining Stock
DexCom VP John Lister Unloads 3,518 Shares
DexCom VP John Lister Unloads 3,518 Shares


Leave a Reply

 
© 2006-2014 Mideast Time.